載入...
Lasting Prolonged-Release Tapentadol for Moderate/Severe Non-Cancer Musculoskeletal Chronic Pain
INTRODUCTION: Despite opioids’ recognized role in the treatment of moderate/severe musculoskeletal chronic pain, their long-term benefits need investigation. We explored the lasting analgesic efficacy, tolerability, influence on life quality, and chronicity stage of the novel prolonged release (PR)...
Na minha lista:
| 發表在: | Pain Ther |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Springer Healthcare
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4470964/ https://ncbi.nlm.nih.gov/pubmed/25558866 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40122-014-0030-6 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|